PTPN22 interacts with EB1 to regulate T-cell receptor signaling

被引:12
|
作者
Zhang, Xiaonan [1 ]
Yu, Yang [1 ]
Bai, Bin [1 ]
Wang, Tao [1 ]
Zhao, Jiahui [1 ]
Zhang, Na [1 ]
Zhao, Yanjiao [1 ]
Wang, Xipeng [1 ]
Wang, Bing [1 ]
机构
[1] Northeastern Univ, Inst Biochem & Mol Biol, Coll Life & Hlth Sci, Shenyang 110169, Peoples R China
基金
中国国家自然科学基金;
关键词
autoimmune diseases; protein interactions; TCR signaling pathway; tyrosine phosphatase; LYMPHOID TYROSINE PHOSPHATASE; MICROTUBULE DYNAMIC INSTABILITY; END BINDING-PROTEINS; RHEUMATOID-ARTHRITIS; SH2; DOMAIN; ASSOCIATION; POLYMORPHISM; VARIANT; KINASE; ACTIVATION;
D O I
10.1096/fj.201902811RR
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The PTPN22 gene encoding the Lyp/Pep protein tyrosine phosphatase is a negative regulator of T-cell receptor (TCR) signaling. Recent studies have shown that phosphorylation of end-binding protein 1 (EB1) is associated with the TCR activation. In this study, using 2-hybrid and mass spectrometry analyses, we identified EB1 as a protein associated with PTPN22. Furthermore, we discovered that EB1 specifically bound to the P1 domain of PTPN22 by competing with CSK, and the variant PTPN22-R620W does not affect the association with EB1, which is instrumental with respect to the regulation of TCR signaling. In addition, PTPN22 dephosphorylates EB1 at tyrosine-247 (Y247), which decreases the expression of the T-cell activation markers CD25 and CD69 and the phosphorylation levels of the TCR molecules ZAP-70, LAT, and Erk, leading to the eventual downregulation of the transcription factor NFAT and reduced the levels of secreted IL-2. The findings of this study provide new insights into the TCR signaling and the T-cell immune response, which are important for clarifying the mechanism of PTPN22-related autoimmune diseases.
引用
收藏
页码:8959 / 8974
页数:16
相关论文
共 50 条
  • [1] Regulation of T Cell Signaling and Immune Responses by PTPN22
    Brownlie, Rebecca J.
    Salmond, Robert J.
    MOLECULAR AND CELLULAR BIOLOGY, 2024, 44 (10) : 443 - 452
  • [2] Regulation of autoimmune and anti-tumour T-cell responses by PTPN22
    Brownlie, Rebecca J.
    Zamoyska, Rose
    Salmond, Robert J.
    IMMUNOLOGY, 2018, 154 (03) : 377 - 382
  • [3] PTPN22 and the pathogenesis of ulcerative colitis: Insights into T cell differentiation and the JAK/STAT signaling pathway
    Yu, Yang
    Ba, Xinlei
    Li, Tong
    Xu, Wenying
    Zhao, Jiahui
    Zhang, Na
    Zhao, Yanjiao
    Wang, Tao
    Zhang, Xiaonan
    Wang, Xipeng
    Bai, Bin
    Wang, Bing
    CELLULAR SIGNALLING, 2025, 127
  • [4] Analysis of PTPN22 C1858T gene polymorphism in cases with type 1 diabetes of Azerbaijan, Northwest Iran
    Almasi, Shohreh
    Aliparasti, Mohammad Reza
    Yazdchi-Marandi, Leili
    Aliasgarzadeh, Akbar
    Sioofy-Khojine, Amirbabak
    Mesri, Adel
    Zamani, Fatemeh
    CELLULAR IMMUNOLOGY, 2014, 292 (1-2) : 14 - 18
  • [5] UBASH3A Interacts with PTPN22 to Regulate IL2 Expression and Risk for Type 1 Diabetes
    Newman, Jeremy R. B.
    Concannon, Patrick
    Ge, Yan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (10)
  • [6] Androgens contribute to sex bias of autoimmunity in mice by T cell-intrinsic regulation of Ptpn22 phosphatase expression
    Lee, Jean
    Yurkovetskiy, Leonid A.
    Reiman, Derek
    Frommer, Lara
    Strong, Zoe
    Chang, Anthony
    Kahaly, George J.
    Khan, Aly A.
    Chervonsky, Alexander V.
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [7] Altered B Cell Homeostasis and Toll-Like Receptor 9-Driven Response in Type 1 Diabetes Carriers of the C1858T PTPN22 Allelic Variant: Implications in the Disease Pathogenesis
    Gianchecchi, Elena
    Crino, Antonino
    Giorda, Ezio
    Luciano, Rosa
    Perri, Valentina
    Lo Russo, Anna
    Cappa, Marco
    Rosado, M. Manuela
    Fierabracci, Alessandra
    PLOS ONE, 2014, 9 (10):
  • [8] Protein tyrosine phosphatase non-receptor type 22 (PTPN22)+1858 C>T gene polymorphism in Egyptian cases with rheumatoid arthritis
    Salama, Afrah
    Elshazli, Rami
    Elsaid, Afaf
    Settin, Ahmad
    CELLULAR IMMUNOLOGY, 2014, 290 (01) : 62 - 65
  • [9] Susceptibility to type 1 diabetes conferred by the PTPN22 C1858T polymorphism in the Spanish population
    Luis Santiago, Jose
    Martinez, Alfonso
    de la Calle, Hermenegildo
    Fernandez-Arquero, Miguel
    Angeles Figueredo, M.
    de la Concha, Emilio G.
    Urcelay, Elena
    BMC MEDICAL GENETICS, 2007, 8
  • [10] TRAF3 enhances type I interferon receptor signaling in T cells by modulating the phosphatase PTPN22
    Hornick, Emma L.
    Wallis, Alicia M.
    Bishop, Gail A.
    SCIENCE SIGNALING, 2022, 15 (753)